By inhibiting the hypothalamic NPY signaling pathway, insulin secretion will be increased (Konner and Bruning, 2012; Loh et al., 2015), thus participating in the pathogenesis of type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.